LeMaitre to Present at the Needham Virtual Healthcare Conference

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that Chief Financial Officer JJ Pellegrino will present at the 21st Annual Needham Virtual Healthcare Conference on April 14, 2022, at 10:15 AM ET. LeMaitre specializes in devices and services for treating peripheral vascular disease, impacting over 200 million globally. The company focuses on developing disposable and implantable vascular devices tailored for vascular surgeons.

BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 10:15 AM ET.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

When is the LeMaitre Vascular presentation at the Needham Virtual Healthcare Conference?

LeMaitre Vascular will present on April 14, 2022, at 10:15 AM ET.

Who is presenting for LeMaitre Vascular at the Needham Conference?

JJ Pellegrino, the Chief Financial Officer, will present at the conference.

What is the focus of LeMaitre Vascular's business?

LeMaitre Vascular provides devices and services for treating peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

More than 200 million people are affected by peripheral vascular disease globally.

What products does LeMaitre Vascular develop?

LeMaitre develops disposable and implantable vascular devices for vascular surgeons.